These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 32241823)

  • 1. Autoimmune hemolytic anemia, demyelinating relapse, and AQP1 antibodies after alemtuzumab infusion.
    Tzartos JS; Valsami S; Tzanetakos D; Stergiou C; Dandoulaki M; Barbarousi D; Psimenou E; Velonakis G; Stefanis L; Kilidireas K
    Neurol Neuroimmunol Neuroinflamm; 2020 May; 7(3):. PubMed ID: 32241823
    [No Abstract]   [Full Text] [Related]  

  • 2. Life-threatening autoimmune warm hemolytic anemia following treatment for multiple sclerosis with alemtuzumab.
    Meunier B; Rico A; Seguier J; Boutiere C; Ebbo M; Harle JR; Schleinitz N; Pelletier J
    Mult Scler; 2018 May; 24(6):811-813. PubMed ID: 29359614
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Simultaneous early-onset severe autoimmune hemolytic anemia and albuminuria during alemtuzumab treatment for multiple sclerosis.
    di Ioia M; Farina D; di Tommaso V; Travaglini D; Pietrolongo E; Onofrj M; de Luca G
    Mult Scler; 2018 May; 24(6):813-815. PubMed ID: 29359617
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Severe autoimmune intravascular hemolytic anemia in patients receiving alemtuzumab for multiple sclerosis.
    Sharma P; Saksena A; Diaz A; Pang Y; Desai P
    Blood Adv; 2023 Jun; 7(11):2534-2537. PubMed ID: 36375041
    [No Abstract]   [Full Text] [Related]  

  • 5. Alemtuzumab-induced simultaneous onset of autoimmune haemolytic anaemia, alveolar haemorrhage, nephropathy, and stroke: A case report.
    Alnahdi MA; Aljarba SI; Al Malik YM
    Mult Scler Relat Disord; 2020 Jun; 41():102141. PubMed ID: 32446212
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A case of severe Legionella pneumonia following alemtuzumab infusion for multiple sclerosis.
    Spurgeon EN; Abbatemarco JR; Miranda C; Rensel MR
    Clin Neurol Neurosurg; 2020 Sep; 196():105961. PubMed ID: 32554236
    [No Abstract]   [Full Text] [Related]  

  • 7. B cell depletion therapy resulting in sustained remission of severe autoimmune complications following Alemtuzumab treatment of Multiple Sclerosis.
    Massey J; Barnett Y; Curnow J; Sutton I
    Mult Scler Relat Disord; 2019 Oct; 35():100-103. PubMed ID: 31357122
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Refractory chronic spontaneous urticaria after the use of alemtuzumab in multiple sclerosis.
    Hu H; Reddell S; Riminton S; Chan C; Urriola N
    Neurol Neuroimmunol Neuroinflamm; 2020 Jan; 7(2):. PubMed ID: 31915266
    [No Abstract]   [Full Text] [Related]  

  • 9. Marked neutropenia: Significant but rare in people with multiple sclerosis after alemtuzumab treatment.
    Baker D; Giovannoni G; Schmierer K
    Mult Scler Relat Disord; 2017 Nov; 18():181-183. PubMed ID: 29141806
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Autoimmune encephalitis following alemtuzumab treatment of multiple sclerosis.
    Giarola B; Massey J; Barnett Y; Rodrigues M; Sutton I
    Mult Scler Relat Disord; 2019 Feb; 28():31-33. PubMed ID: 30553166
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Alemtuzumab treatment of multiple sclerosis in real-world clinical practice: A report from a single Italian center.
    di Ioia M; Di Stefano V; Farina D; Di Tommaso V; Travaglini D; Pietrolongo E; Sensi SL; Onofrj M; De Luca G
    Mult Scler Relat Disord; 2020 Feb; 38():101504. PubMed ID: 31733426
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Detecting and predicting neutralization of alemtuzumab responses in MS.
    Saxena G; Moore JM; Jones M; Pryce G; Ali L; Leisegang GR; Vijay V; Loveless S; Robertson NP; Schmierer K; Giovannoni G; Gnananpavan S; Baker D; Tallantyre EC; Kang AS
    Neurol Neuroimmunol Neuroinflamm; 2020 Jul; 7(4):. PubMed ID: 32499328
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Acute cardiotoxicity associated with alemtuzumab infusion for multiple sclerosis.
    Ahrabian D; Neill L; Bell R; Leary SM
    Mult Scler; 2020 May; 26(6):735-737. PubMed ID: 32298216
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A case of longitudinally extensive transverse myelitis (LETM): neuromyelitis optica.
    Mangat P; Ravindran J; Cleland L; Limaye V
    Clin Rheumatol; 2008 Dec; 27 Suppl 2():S67-9. PubMed ID: 18560921
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immune profiling of a patient with alemtuzumab-associated progressive multifocal leukoencephalopathy.
    Gerevini S; Capra R; Bertoli D; Sottini A; Imberti L
    Mult Scler; 2019 Jul; 25(8):1196-1201. PubMed ID: 30964396
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neutropenia with fatal outcome in a multiple sclerosis patient 23 days after alemtuzumab infusion.
    Yiannopoulou KG; Papadimitriou D; Anastasiou AI; Siakantaris M
    Mult Scler Relat Disord; 2018 Jul; 23():15-16. PubMed ID: 29730587
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lambert-Eaton myasthenic syndrome associated with alemtuzumab administration.
    Hoffman BM; Zeid NA; Alam U; Caress JB
    Mult Scler Relat Disord; 2019 Jan; 27():131-132. PubMed ID: 30384197
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pneumonitis secondary to alemtuzumab in a patient with multiple sclerosis - A non-infectious cause of breathlessness.
    Whiteside D; Barth S; Datta A; Trip SA
    Mult Scler Relat Disord; 2018 May; 22():139-140. PubMed ID: 29684788
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Acute myocardial infarction associated with initial alemtuzumab infusion cycle in relapsing-remitting multiple sclerosis.
    Romba MC; Newsome SD; McArthur JC
    Mult Scler Relat Disord; 2019 Sep; 34():100-102. PubMed ID: 31252364
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Acute leukocytosis during alemtuzumab treatment in patients with active relapsing-remitting multiple sclerosis.
    Iovino A; Aruta F; Carotenuto A; Manganelli F; Iodice R
    Mult Scler Relat Disord; 2019 Feb; 28():98-100. PubMed ID: 30580038
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.